Press Releases

PDA Technical Reports are highly valued, global technical documents prepared by member-driven Task Forces comprised of content experts, including scientists and engineers working in the pharmaceutical and biopharmaceutical industry, regulatory authorities and academia.

Bethesda, Md., October 31, 2012 – The Parenteral Drug Association (PDA) is proud to announce the founding of the PDA India Chapter, which will serve PDA members in India.

“This is the most innovative and significant member benefit ever offered by The Parenteral Drug Association (PDA),” said Richard M. Johnson, PDA President. “We have been working hard on enhancing our member value and we believe that releasing this new Technical Report Portal by the end of 2012 is a breakthrough benefit that you just don’t see anywhere.

Our industry is entering a challenging phase for the next decade in the area of pre-filled syringes & injection devices. Costs and regulatory demands exert downward pressure on our ability to introduce devices that are safe and effective. Patients and their needs continue to grow while ever more complex molecules continue to challenge our material selection. Regulatory requirements, industry experience and evolving market trends are critical considerations to ensure a complete understanding of the application of pre-filled syringes and injection devices to drug delivery.

Bethesda, Md., July 16, 2012 – St Petersburg, Russia (June 22, 2012) – The Parenteral Drug Association (PDA) and The Saint-Petersburg State Chemical-Pharmaceutical Academy (SPCPA) have signed a Memorandum of Understanding to develop a GMP and Regulatory Affairs Training Center in the area of pharmaceutical manufacturing in St. Petersburg (the Training Center).

The Parenteral Drug Association (PDA) is coordinating a critical discussion on the implementation of QbD concepts in vaccine development.Five vaccine manufacturers (GlaxoSmithKline, MedImmune, Merck, Pfizer and Sanofi Pasteur) have joined to form the CMC-VWG, with assistance from PricewaterhouseCoopers, to create a case study describing the development of the fictitious vaccine A-Vax. The goal of the workshop is to initiate a discussion of the case study and to provide a review of the QbD approaches employed for the development of A-Vax.

PDA is pleased to announce the results of the 2012 Board of Directors and Officers election. The elected candidates will fill their term beginning on January 1, 2012. Thank you to all who voted!

Bethesda, Md., September 7, 2011 – The Parenteral Drug Association (PDA) is pleased to announce new measures enhancing the availability of PDA membership including an expanded Emerging Economy membership, a new option for Retired Membership, and additional assistance for members who are currently seeking employment in the Pharmaceutical industry.

Bethesda, Md., August 8, 2011 – The Parenteral Drug Association (PDA) is proud to announce that Deborah Autor, Deputy Commissioner for Global Regulatory Operations and Policy will give the Opening Keynote speaker at the 2011 PDA/FDA Joint Regulatory Conference & TRI Courses, Sept. 19-21, Renaissance Washington Hotel in Washington, D.C.

US FDA Commissioner, Dr. Margaret Hamburg, calls for closer and more global cooperation on GMP at PIC/S 40th Anniversary

PDA along with the US FDA hosted the 2011 PDA/FDA Glass Quality Conference & TRI Courses on May 23-26, 2011 in Arlington, Virginia. “The first-time event had great content and participation [and]...brought to the table the most relevant topics,” said Richard M. Johnson, PDA President.

PDA is working on improving member engagement and their satisfaction is at the forefront of our decision to invest in a new web site with enhanced navigation.

Hear from the US FDA, National Institute of Health and More at PDA’s 2010 Pharmaceutical Freeze Drying Workshop

PDA’s Board of Director’s Chairman, Maik Jornitz, Was Recently Promoted to Head, Operational Marketing of Sartorius Stedim Biotech.

Bethesda, Md. – PDA/FDA's Joint Regulatory Conference recently held in Washington, D.C. has been an overwhelming success with over 800 regulators and scientists attending and discussing current and upcoming regulatory trends and quality requirements.

Bethesda, Md. – The Parenteral Drug Association (PDA) is proud to announce the confirmation of expert regulatory speakers at this year’s Global Conference on Pharmaceutical Microbiology.

Bethesda, Md. – The Parenteral Drug Association (PDA) is proud to announce that Rebeca Rodriquez, National Expert Investigator, FDA is confirmed to give an Overview of Personnel Qualification Issues found during FDA Inspections in Baltimore, Maryland on October 12.

2010 PDA/FDA Joint Regulatory Conference Announces Key Industry and Government Leaders as Speakers

PDA Announces Establishment of New Chapter

U.S. FDA Commissioner to give Keynote Presentation at the 2010 PDA/FDA Joint Regulatory Conference